Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemcrux Enterprises reported Q1FY26 standalone revenue from operations of about Rs. 1,674.74 lacs, up modestly from Rs. 1,596.56 lacs in Q1FY25 (roughly 5% YoY growth). Total standalone income rose to Rs. 1,735.44 lacs from Rs. 1,624.30 lacs a year ago. Standalone profit before tax was nearly flat at Rs. 73.06 lacs versus Rs. 72.79 lacs in Q1FY25, while basic EPS improved to Rs. 0.39 from Rs. 0.32. On a consolidated basis, revenue from operations stood at Rs. 1,650.35 lacs. The statutory auditor, Naresh & Co., issued an unqualified limited review report on both standalone and consolidated results. The filing also notes that Kalichem Private Limited became a wholly-owned subsidiary from February 27, 2025, after Chemcrux acquired the remaining 50% stake it did not already own.
Headline numbers are steady but unspectacular, with revenue growing in single digits and bottom-line nearly flat — unlikely to trigger a sharp share-price move. The full ownership of subsidiary Kalichem could provide longer-term consolidation benefits and synergies, but near-term impact on Q1FY26 standalone numbers is limited.